Clinical Trial Update: Serum METRNL Concentration in Type 2 Diabetes

View source ↗

Summary

A clinical trial evaluating serum METRNL concentration in individuals with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Chungnam National University Hospital | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED